CLINICAL_TRIALS
trial_result
· 2016-01-21
Clinical Trial Update: 104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants [Phase 2]
Summary
Phase 2 trial of BG9924 in rheumatoid arthritis was terminated. The document reports safety and efficacy assessments from the trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED